AbCellera Biologics's market cap is currently $1.42B. The company's EPS TTM is $-0.12; its P/E ratio is ―; AbCellera Biologics is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
